The ovarian adenocellular hyperplasia syndrome refers to a group of symptoms and signs that appear in patients, including a series of symptoms such as feminization and pathologic changes such as follicular membrane cell hyperplasia. This syndrome was described by Culiner and Shippel as early as 1949, indicating that there are florigenized follicular membrane cells in the stroma, but they are not related to adjacent follicles. Subsequently, it was found that they often accompany maleification. Originally, this kind of disease was included in the polycystic ovary syndrome, but in recent years, due to the progress of steroid determination methods and the clinical application of clomiphene, the diagnosis of this syndrome has been greatly helped. Since clomiphene can cause ovulation (ovulation rate up to 75%) in polycystic ovary syndrome cases, but it is ineffective for this syndrome. Therefore, it is necessary to distinguish this syndrome from the polycystic ovary syndrome.